BoneScore® for Physicians
BoneScore®, using the FDA-cleared OsteoProbe, is the first direct measurement of bone material strength, significantly correlating with whole bone strength at the hip, wrist, and spine, as validated by peer-reviewed cadaver testing. This radiation-free test provides a new data point that can be tracked over shorter timeframes to monitor changes offering a more complete picture of your patient’s bone health.
There’s more to bone strength than density.
Strong, healthy bones require good structure, adequate mineral density, and high tissue quality. DXA provides indirect imaging of bone density but offers no insight into tissue function or quality. Other imaging (e.g., CT Scan/MRI) reveals structure but fails to quantify tissue resilience. BoneScore® addresses this gap by directly measuring bone tissue’s response to a microscopic challenge, providing critical data to help your physician make informed decisions.
The assessment of tissue quality remains elusive.
Tissue quality is a composite of properties that make bone resist fracture, such as its microarchitecture, accumulated microscopic damage, the quality of collagen, mineral crystal size, and bone turnover.3 Bone Score® is the first tool to directly measure bone material strength, accurately correlating with whole bone strength at critical sites, as shown in peer-reviewed cadaver studies.
A direct approach offers new information.
BoneScore® answers the critical question: “How strong is the bone tissue in my patient?” By directly measuring bone tissue strength, BoneScore® provides you with new data for hip, wrist, and spine strength and fracture toughness, surpassing DXA’s capabilities for non-osteoporotic bones
BoneScore® enables physicians to directly measure a patient’s bone tissue.
BoneScore® is an in-office procedure that quantifies a patient’s bone material strength. Combined with other tools like DXA and FRAX, you can make the most informed decisions for your patients.
How BoneScore® Works
BoneScore® is a brief, in-office procedure.
BoneScore® is a brief, in-office procedure performed at the mid-shaft of the anterior tibia using the OsteoProbe®. It directly feels the bone tissue and quantifies its resistance to a safe, microscopic challenge, accurately correlating with whole bone strength at the hip, wrist, and spine.
The BoneScore® procedure results in a simple numerical score.
BoneScore® offers a first of its kind scale to quantify the strength of bone tissue.
Higher Bone Scores reflect greater resistance to the microscopic challenge (i.e., harder) and lower numbers reflect lesser resistance to the microscopic challenge (i.e., softer).
Patient Bone Scores fall between 45 (low) to 105 (high).
Include bone strength and fracture toughness in your analysis.
Osteoporosis diagnosis and treatment decisions will continue to rely on the established technologies (e.g., DXA) and clinical guidelines. BoneScore® is valuable for making informed decisions about a patient’s bone strength and fracture toughness. BoneScore® is not intended to be used by itself to diagnose a disease or prescribe a therapy.
1. Licata, A., Bone density vs bone quality: What’s a clinician to do? Cleveland Clinic Journal of Medicine, 2009. 76(6): p. 331-36.
2. Unnanuntana, A., et al., Diseases affecting bone quality: beyond osteoporosis. Clin Orthop Relat Res, 2011. 469(8): p. 2194-206.
3. Felsenberg, D. and S. Boonen, The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther, 2005. 27(1): p. 1-11.
